Syncom Formulations (India) Ltd. — Board/Management Information 2024

Oct 3, 2024

SYNCOM/SE/2024-25

==> picture [452 x 73] intentionally omitted <==

3[rd] October, 2024

Online filing at: www.listing.bseindia.com and

https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF

Sub: Disclosure under regulation 30 of the SEBI (LODR) Regulation, 2015 read with subclause 7 of Para A of Part A of Schedule: Change in Directorate.

Dear Sir/Madam,

Pursuant to the Regulation 30 of the SEBI(LODR)Regulation, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13[th] July 2023, we are pleased to inform that the members of the Company in their 36[th] Annual General Meeting held on Monday, 30[th] September, 2024 at 2:00 P.M. approved the following changes in the Board of Directors of the Company:

1. Re-appointment of Shri Kedarmal Shankarlal Bankda (DIN:00023050) as the Executive Chairman/ Whole-time Director of the Company:

• The Members of the Company have approved confirmation of the re-appointment of Shri Kedarmal Shankarlal Bankda (DIN:00023050) as the Executive Chairman/ Whole-time Director of the company for a further period of 2 (Two) years w.e.f. 2[nd] May 2025.

2. Re-appointment of Shri Vijay Shankarlal Bankda (DIN:00023027) as the Managing Director of the Company:

The Members of the Company have approved confirmation of the re-appointment of Shri Vijay Shankarlal Bankda (DIN: 00023027) as the Managing Director of the company for a further period of 2 (Two) years w.e.f. 29[th] November 2024.

Additional details as required under Regulation 30 and other applicable regulations of SEBI (LODR) Regulations, 2015, as amended from time to time are given as Annexure-1 and Annexure-2. We are also in process to file the aforesaid Disclosure in XBRL format within the stipulated time.

Thanking You Yours Faithfully,

For, SYNCOM FORMULATIONS (INDIA) LIMITED

VAISHALI Digitally signed by VAISHALI AGRAWAL AGRAWAL Date: 2024.10.03 18:35:11 +05'30' CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

Encl.: Disclosures as above.

==> picture [452 x 73] intentionally omitted <==

==> picture [452 x 73] intentionally omitted <==

Annexure-1

DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13[TH] JULY 2023

1. Confirmation of re-appointment of Shri Kedarmal Shankarlal Bankda (DIN:00023050) as the Executive Chairman/ Whole-time Director of the company under the category of Executive Director w.e.f. 2[nd] May 2025 for a further period of 2 (Two) years:

a		Reason for change viz.~~appointment~~, re- appointment,~~resignation, removal, death~~ ~~or otherwise;~~(tenure completion)	Shri Kedarmal Shankarlal Bankda (DIN:00023050) who was re-appointed as the Executive Chairman/ Whole-time Director (in the category of Executive Director) by the Board of Directors at their meeting held on 12th August 2024. Based on the recommendation of the Board of Directors, the members have confirmed the re-appointment of Shri Kedarmal Shankarlal Bankda, as an Executive Chairman/ Whole-time Director of the company for a further period of 2 years w.e.f. May 2, 2025, in the Annual General Meeting held on 30th September 2024.
b		Date of ~~appointmen~~t/re-appointment ~~/cessation~~(as applicable) & term of appointment/re-appointment	2ndMay, 2025 for further tenure of two (2) years
c		Profile (in case of appointment);	Shri Kedarmal Shankarlal Bankda (DIN:00023050) is a Post Graduate in commerce and is the core promoter of the company since incorporation and having 48 years all around working experience and looking into all the manufacturing and administrative functions of the Corporate Office of the company at Indore and Plant at Pithampur. It would be in the interest of the Company to continue the employment of Shri Kedarmal Shankarlal Bankda as Chairman & Whole-Time Director of the Company
d		Disclosure of relationships between directors (in case of appointment of a director).	He is brother of Shri Vijay Shankarlal Bankda, Managing Director, Father in law of Mrs. Rinki Ankit Bankda, WTD and father of Shri Ankit Kedarmal Bankda, CFO.

For, SYNCOM FORMULATIONS (INDIA) LIMITED

VAISHALI Digitally signed by VAISHALI AGRAWAL AGRAWAL Date: 2024.10.03 18:35:32 +05'30' CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [452 x 73] intentionally omitted <==

==> picture [452 x 73] intentionally omitted <==

Annexure-2

DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13[TH] JULY 2023

2. Confirmation of re-appointment of Shri Vijay Shankarlal Bankda (DIN:00023027) as the Managing Director of the company under the category of Executive Director w.e.f. 29[th] November, 2024 for a further period of 2 (Two) years:

a		Reason for change viz.~~appointment,~~re- appointment,~~resignation, removal, death~~ ~~or otherwise;~~(tenure completion)	Shri Vijay Shankarlal Bankda (DIN 00023027) who was re- appointed as the Managing Director (in the category of Executive Director) by the Board of Directors at their meeting held on 12thAugust 2024. Based on the recommendation of the Board of Directors, the members have confirmed the re-appointment of Shri Vijay Shankarlal Bankda, as a Managing Director of the company for a further period of 2 years w.e.f. 30thNovember 2024, in the Annual General Meeting held on 30thSeptember 2024.
b		Date of ~~appointment~~/re-appointment/ ~~cessation~~(as applicable) & term of ~~appointment/~~re-appointment	29thNovember, 2024 for further tenure of two (2) years
c		Profile (in case of appointment);	Shri Vijay Shankarlal Bankda is a Post Graduate in commerce and is the core promoter of the company since incorporation and having 46 years of experience in the pharmaceutical filed in various capacitates and also attending commercial operations of the Company, his experience, commitment and capabilities are playing crucial role in the growth of the Company. It would be in the interest of the Company to continue the employment of Shri Vijay Shankarlal Bankda as Managing Director of the Company
d		Disclosure of relationships between directors (in case of appointment of a director).	He is brother of Shri Kedarmal Shankarlal Bankda, Chairman and WTD, and relative of Mrs. Rinki Ankit Bankda, WTD and Shri Ankit Kedarmal Bankda,CFO.

For, SYNCOM FORMULATIONS (INDIA) LIMITED

VAISHALI Digitally signed by VAISHALI AGRAWAL AGRAWAL Date: 2024.10.03 18:35:52 +05'30' CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [452 x 73] intentionally omitted <==